SEC Form 4 · accession 0001127602-17-023514
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman, President and CEO · Director
Period of report
Jul 10, 2017
Accepted (ET)
Jul 12, 2017 · 7:09 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 10, 2017 | S | 7 | $98.755 | D | 361,171 | D | |
| Common Stock | Jul 10, 2017 | S | 400 | $98.76 | D | 360,771 | D | |
| Common Stock | Jul 10, 2017 | S | 100 | $98.77 | D | 360,671 | D | |
| Common Stock | Jul 10, 2017 | S | 93 | $98.78 | D | 360,578 | D | |
| Common Stock | Jul 10, 2017 | S | 300 | $98.79 | D | 360,278 | D | |
| Common Stock | Jul 10, 2017 | S | 100 | $98.825 | D | 360,178 | D | |
| Common Stock | Jul 10, 2017 | S | 900 | $98.84 | D | 359,278 | D | |
| Common Stock | Jul 10, 2017 | S | 200 | $98.86 | D | 359,078 | D | |
| Common Stock | Jul 10, 2017 | S | 304 | $98.88 | D | 358,774 | D | |
| Common Stock | Jul 10, 2017 | S | 384 | $98.89 | D | 358,390 | D | |
| Common Stock | Jul 10, 2017 | S | 300 | $98.90 | D | 358,090 | D | |
| Common Stock | Jul 10, 2017 | S | 200 | $98.91 | D | 357,890 | D | |
| Common Stock | Jul 10, 2017 | S | 211 | $98.915 | D | 357,679 | D | |
| Common Stock | Jul 10, 2017 | S | 589 | $98.92 | D | 357,090 | D | |
| Common Stock | Jul 10, 2017 | S | 400 | $98.925 | D | 356,690 | D | |
| Common Stock | Jul 10, 2017 | S | 100 | $98.93 | D | 356,590 | D | |
| Common Stock | Jul 10, 2017 | S | 300 | $98.94 | D | 356,290 | D | |
| Common Stock | Jul 10, 2017 | S | 500 | $98.95 | D | 355,790 | D | |
| Common Stock | Jul 10, 2017 | S | 1 | $98.955 | D | 355,789 | D | |
| Common Stock | Jul 10, 2017 | S | 499 | $98.96 | D | 355,290 | D | |
| Common Stock | Jul 10, 2017 | S | 200 | $98.965 | D | 355,090 | D | |
| Common Stock | Jul 10, 2017 | S | 400 | $98.97 | D | 354,690 | D | |
| Common Stock | Jul 10, 2017 | S | 70 | $98.975 | D | 354,620 | D | |
| Common Stock | Jul 10, 2017 | S | 1,114 | $98.98 | D | 353,506 | D | |
| Common Stock | Jul 10, 2017 | S | 14 | $98.985 | D | 353,492 | D | |
| Common Stock | Jul 10, 2017 | S | 1,830 | $98.99 | D | 351,662 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.